Fibrinogen/Albumin Ratio is Associated with the Occurrence of Contrast-Induced Acute Kidney Injury in Patients with Congestive Heart Failure

被引:0
作者
Zhang, Guanghui [1 ]
Huang, Dehua [1 ]
Chen, Jieyi [1 ]
Yang, Xi [1 ]
Ruan, Huangtao [2 ]
Huang, Xiaoyu [3 ]
机构
[1] Guangdong Med Univ, Clin Med Coll 1, Zhanjiang, Guangdong, Peoples R China
[2] Guangdong Prov Peoples Hosp, Dept Guangdong Prov Key Lab Coronary Heart Dis Pre, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Med Univ, Yangjiang Hosp, Cardiovasc Intens Care Unit, Yangjiang, Guangdong, Peoples R China
关键词
fibrinogen/albumin ratio; FAR; contrast-induced acute kidney injury; CI-AKI; congestive heart failure; CHF; biomarker; prognosis; PERCUTANEOUS CORONARY INTERVENTION; INDUCED NEPHROPATHY; BLOOD-VISCOSITY; ADHESION MOLECULE-1; OXIDATIVE STRESS; ARTERY-DISEASE; ALBUMIN RATIO; SEVERITY; RISK; INFLAMMATION;
D O I
10.2147/JIR.S507160
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Patients with congestive heart failure (CHF) are associated with an elevated risk of mortality and poor prognosis. Contrastinduced acute kidney injury (CI-AKI), a common complication in CHF patients undergoing contrast-enhanced procedures, exacerbates renal dysfunction and contributes to adverse outcomes. However, the relationship between the preoperative fibrinogen/albumin ratio (FAR) and the risk of CI-AKI or all-cause mortality in CHF remains unclear. This study analyzed the correlation of FAR with the risk of CI-AKI and all-cause mortality in patients with CHF. Patients and Methods: In this retrospective observational study, CHF patients undergoing coronary angiography (CAG) were enrolled and grouped according to their FAR quartiles. The association between FAR and clinical outcomes was assessed using the multivariate logistic regression and restricted cubic spline (RCS) analyses. Results: This study included 7,235 CHF patients with a mean age of 65.8 +/- 11.7 years. Among these, 2,100 were female (29.0%), and 1,094 (15.1%) experienced CI-AKI. FAR showed a non-linear relationship with CI-AKI (p < 0.001). The risk of CI-AKI was significantly higher with increasing FAR. After adjusting for all the potential confounding variables, the risk of CI-AKI was highest in patients with FAR >0.150 (OR = 1.572, 95% CI 1.237-2.004, p < 0.001). Multivariate COX proportional risk model showed that the risk of all-cause mortality was highest in CHF patients with FAR > 0.150 (HR = 1.20, 95% CI 1.04-1.38, p = 0.014). Conclusion: FAR is an independent risk factor for the occurrence of CI-AKI in patients with CHF.
引用
收藏
页码:5149 / 5159
页数:11
相关论文
共 61 条
[1]   Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease [J].
Albert, Michelle A. ;
Glynn, Robert J. ;
Buring, Julie E. ;
Ridker, Paul M. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (09) :1246-1251
[2]   Serum albumin level and long-term outcome in acute heart failure [J].
Ancion, Arnaud ;
Allepaerts, Sophie ;
Robinet, Sebastien ;
Oury, Cecile ;
Pierard, Luc A. ;
Lancellotti, Patrizio .
ACTA CARDIOLOGICA, 2019, 74 (06) :465-471
[3]   Oxidative Stress and Paraoxonase 1 Activity Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [J].
Borekci, Abdurrezzak ;
Gur, Mustafa ;
Turkoglu, Caner ;
Cayli, Murat ;
Selek, Sahbettin ;
Kaypakli, Onur ;
Ucar, Hakan ;
Coskun, Mehmet ;
Seker, Taner ;
Koc, Mevlut ;
Gokdeniz, Teyyar ;
Gozukara, Mehmet Yavuz .
ANGIOLOGY, 2015, 66 (04) :339-345
[4]  
Buyuklu M, 2014, EUR REV MED PHARMACO, V18, P461
[5]   The association between the fibrinogen-to-albumin ratio and coronary artery disease severity in patients with stable coronary artery disease [J].
Celebi, Savas ;
Ozcan Celebi, Ozlem ;
Berkalp, Berkten ;
Amasyali, Basri .
CORONARY ARTERY DISEASE, 2020, 31 (06) :512-517
[6]   Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome [J].
Celik, Ibrahim E. ;
Kurtul, Alparslan ;
Duran, Mustafa ;
Yarlioglues, Mikail ;
Elcik, Deniz ;
Kilic, Alparslan ;
Koseoglu, Cemal ;
Oksuz, Fatih ;
Murat, Sani N. .
CORONARY ARTERY DISEASE, 2016, 27 (01) :13-18
[7]   Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study [J].
Cesari, M ;
Penninx, BWJH ;
Newman, AB ;
Kritchevsky, SB ;
Nicklas, BJ ;
Sutton-Tyrrell, K ;
Rubin, SM ;
Ding, JZ ;
Simonsick, EM ;
Harris, TB ;
Pahor, M .
CIRCULATION, 2003, 108 (19) :2317-2322
[8]   Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation [J].
Cugno, M ;
Mari, D ;
Meroni, PL ;
Gronda, E ;
Vicari, F ;
Frigerio, M ;
Coppola, R ;
Bottasso, B ;
Borghi, MO ;
Gregorini, L .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (01) :85-92
[9]   Fibrinogen as a key regulator of inflammation in disease [J].
Davalos, Dimitrios ;
Akassoglou, Katerina .
SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (01) :43-62
[10]   Whole blood viscosity: Effect of hemodialysis treatment and implications for access patency and vascular disease [J].
Dhar, Promila ;
Eadon, Michael ;
Hallak, Patrick ;
Munoz, Ramon Augustine ;
Hammes, Mary .
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2012, 51 (04) :265-275